US Representative

David Rouzer Authored & Sponsored Legislation

Session

Cosponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB470

Introduced
1/16/25  
Red Snapper Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB474

Introduced
1/16/25  
Lumbee Fairness Act This bill extends federal recognition to the Lumbee Tribe of North Carolina and makes its members eligible for the services and benefits provided to members of federally recognized tribes. Members of the tribe residing in Robeson, Cumberland, Hoke, and Scotland Counties in North Carolina are deemed to be within the delivery area for such services. The Department of the Interior and the Department of Health and Human Services must develop, in consultation with the tribe, a determination of needs to provide the services for which members of the tribe are eligible. Interior may take land into trust for the benefit of the tribe. Finally, North Carolina must exercise jurisdiction over all criminal offenses committed, and all civil actions that arise, on North Carolina lands owned by, or held in trust for, the Lumbee Tribe or any dependent Indian community of the tribe unless jurisdiction is transferred to the United States pursuant to an agreement between the tribe and the state.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB534

Introduced
1/16/25  
Refer
1/16/25  
CONTAINER Act Creating Obstructions Necessary To Address Illegal and Nefarious Entry Rapidly Act

Original Cosponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB472

Introduced
1/16/25  
Restore VA Accountability Act of 2025 Restore Department of Veterans Affairs Accountability Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB524

Introduced
1/16/25  
NO GOTION Act No Official Giveaways Of Taxpayers’ Income to Oppressive Nations Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB569

Introduced
1/21/25  
Birthright Citizenship Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB578

Introduced
1/21/25  
Sarah's LawThis bill requires the Department of Justice or the Department of Homeland Security (DHS) to detain a non-U.S. national (alien under federal law) who is unlawfully present in the United States and has been charged with, arrested for, convicted of, or admits to having committed acts that constitute the essential elements of a crime that resulted in the death or serious bodily injury of another person.DHS must obtain information about the identity of any victims of the crimes for which the detained individual was charged or convicted. DHS shall provide the victim, or a relative or guardian of a deceased victim, with information about the detained individual, including name, date of birth, nationality, immigration status, criminal history, and a description of any related removal efforts.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB583

Introduced
1/21/25  
Refer
1/21/25  
BEACH Act of 2025 Beaches Environmental Assessment and Coastal Health Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB599

Introduced
1/22/25  
Protect Funding for Women's Health Care Act This bill prohibits federal funding of Planned Parenthood Federation of America or its affiliates, subsidiaries, successors, or clinics.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB685

Introduced
1/23/25  
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)